2008Unpublished venueRequires access

Effect of amplified autologous NK and T cells infusion from peripheral blood lymphocyte on tumor immunotherapy

Jinyu Li

Open publisher page 0 citations

Abstract

Objective: To study the change of blood lymphocyte phenotype after amplified autologous NK and T cells infusion from peripheral blood lymphocyte in 22 patients with cancer.Methods: Mixture(named NKTm) of NK and T lymphocytes cells amplified from peripheral blood in malignant tumor patients was infused with 2 weeks interval.Before infusion and 2 weeks after infusion,the lymphocyte phenotype was detected by flow cytometry included CD3+、 CD3+CD4+、 CD3+CD8+、 CD3-CD16-CD56+、 CD3-CD16+CD56-、 CD3-CD16+CD56+、 CD3+CD16-CD56+、 CD3+CD16+CD56-、 CD3+CD16+CD56+.Results: Two weeks after infusion,the phenotype of CD3+、 CD3+CD8+、 CD3+CD4+ cells did not significantly change,while the NK like cells(marked with CD16+/CD56+) statistically incresesd(P0.01).The results did not changed after multiple doses.No side-effects were found.Conclusion: Amplified autologous NK and T Cells infusion from peripheral blood lymphocyte may increase the antitumor immune without any side-effects.

About this research paper

What this paper is about

Objective: To study the change of blood lymphocyte phenotype after amplified autologous NK and T cells infusion from peripheral blood lymphocyte in 22 patients with cancer.Methods: Mixture(named NKTm) of NK and T lymphocytes cells amplified from peripheral blood in malignant tumor patients was infused with 2 weeks interval.Before infusion and 2 weeks after infusion,the lymphocyte phenotype was detected by flow cytometry included CD3+、 CD3+CD4+、 CD3+CD8+、 CD3-CD16-CD56+、 CD3-CD16+CD56-、 CD3-CD16+CD56+、 CD3+CD16-CD56+、 CD3+CD16+CD56-、 CD3+CD16+CD56+.Results: Two weeks after infusion,the phenotype of CD3+、 CD3+CD8+、 CD3+CD4+ cells did not significantly change,while the NK like cells(marked with CD16+/CD56+) statistically incresesd(P0.01).The results did not changed after multiple doses.No side-effects were found.Conclusion: Amplified autologous NK and T Cells infusion from peripheral blood lymphocyte may increase the antitumor immune without any side-effects.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: To study the change of blood lymphocyte phenotype after amplified autologous NK and T cells infusion from peripheral blood lymphocyte in 22 patients with cancer.Methods: Mixture(named NKTm) of NK and T lymphocytes cells amplified from peripheral blood in malignant tumor patients was infused with 2 weeks interval.Before infusion and 2 weeks after infusion,the lymphocyte phenotype was detected by flow cytometry included CD3+、 CD3+CD4+、 CD3+CD8+、 CD3-CD16-CD56+、 CD3-CD16+CD56-、 CD3-CD16+CD56+、 CD3+CD16-CD56+、 CD3+CD16+CD56-、 CD3+CD16+CD56+.Results: Two weeks after infusion,the phenotype of CD3+、 CD3+CD8+、 CD3+CD4+ cells did not significantly change,while the NK like cells(marked with CD16+/CD56+) statistically incresesd(P0.01).The results did not changed after multiple doses.No side-effects were found.Conclusion: Amplified autologous NK and T Cells infusion from peripheral blood lymphocyte may increase the antitumor immune without any side-effects.

Key concepts: CD3, CD16, CD8, Lymphocyte, Flow cytometry, Peripheral blood lymphocyte, Natural killer cell, Immunology

Related papers

Back to paper searchBrowse research topicsOriginal source
Effect of amplified autologous NK and T cells infusion from peripheral blood lymphocyte on tumor immunotherapy — Research Paper | ScholarLens